Impact of a Biophoton Therapy on Patients With Brain Disorders
Recruiting
N/A
Interventional Study
Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- First Institute of All Medicines · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Must meet conditions for approval.
* Must be 18-years or older and stay in a hotel.
* Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
* Can provide informed consent or can be …
Contacts
No contact information available.